ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Madopar LIQ 62.5, Tabletten zur Herstellung einer Suspension zum Einnehmen - 100 Tablette(n)
52377021 Roche Pharma (Schweiz) AG
Madopar LIQ 62.5, Tabletten zur Herstellung einer Suspension zum Einnehmen24.02.1994
  24.02.1994
Levodopa and Decarboxylase Inhibitor (N04BA02)12.02.2004
WHO-DDD 
01.08.100 Tablette(n)
01.08. 
B  
Yes 
IPCI
8.48No
    
10 %18.30
  
7680523770210Synthetika
1585787 
Composition
levodopum 50.00 mg, benserazidum 12.50 mg ut benserazidi hydrochloridum, acidum citricum, amylum pregelificatum, cellulosum microcristallinum, magnesii stearas pro compresso.
Packungsbestandteile
  
 
Active AgentDose
Benserazide12.5 mg
Levodopa50 mg
BAG: Active AgentDose
Benserazide12.5 mg
Levodopa50 mg
 
Inactive agents
Citric Acid
 
 
 
 
Source
Data was imported : 05.09.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home